News

Latest news

Hide mandatory notifications of trade

Mandatory Notification of Trade - Jens Krøis

(Oslo, Norway, 29 September 2016) Reference is made to the announcement on 14 September 2016 regarding the Rights Offering in Bionor Pharma ASA (the “Company”).

STOCK EXCHANGE ANNOUNCEMENT

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES

Primary insider notification – Jens Krøis

Jens Krøis, a primary insider of the Company, has on Thursday 28 September 2016 exercised 165,162 Subscription Rights and following such transaction Jens Krøis holds the following interests in the Company:

 

Name Position Shares Subscription Rights in the Rights Issue
Jens Krøis CFO 270,762 0


The subscription price for the shares is NOK 0.10 per share

Further information
Unni Hjelmaas, Acting CEO, +47 915 19 651, uh@bionorpharma.com
Jens Krøis, CFO, +45 208 01 668, jk@bionorpharma.com

Link to announcement in pdf